A new study has revealed that Psilocybin, Mexican magic mushroom, has positive influences in the processing of human emotions.
The researchers at the Psychiatric University Hospital of Zurich have found that the bioactive component in the Psilocybin manipulates the amygdala, which responds to negative signals, thereby weakening the processing of depressing stimuli.
According to Dr. Rainer Krahenmann this observation is of major clinical significance because current available drugs for the treatment of depression and anxiety disorders are not effective in all patients and are often associated with unwanted side effects.
The research was published in Biological Psychiatry.
